Warnex Inc. (TSX VENTURE:WNX.H) ("Warnex" or the "Company") announced today
financial results for the first quarter ended March 31, 2014.
As announced on May 5, 2014, the Company has entered into a binding letter of
agreement with Diagnos pursuant to which Warnex will merge with a wholly-owned
subsidiary of Diagnos. The transaction remains subject to certain closing
conditions including without limitation, (i) satisfactory completion of the due
diligence investigation by Warnex; (ii) receipt of all necessary approvals and
consents, including but not limited to, the approval of the TSX Venture
Exchange; (iii) approval by a majority of the Warnex shareholders at a special
meeting of shareholders scheduled for June 26, 2014, and such other closing
conditions customary for transactions of this nature as may be specified in the
definitive agreement.
Financial results
Net loss for the quarter amounted to $99,402, or $nil per share compared to net
loss of $453,637 or $0.02 per share for the same quarter in 2013. The Board
continues to be focused on reducing expenses, as evidenced by lower general and
administrative expenses, and is expecting this trend to continue going forward.
General and administrative expenses amounted to $105,311 for the quarter
compared to $452,119 for the same quarter last year. General and administrative
expenses decreased as a result of lower facility operating costs amounting to
approximately $120,000 as a result of the lease termination effective December
2013, reduced legal fees due to one-time mandates in the first quarter of 2013
amounting to approximately $180,000 and reduced board of director fees amounting
to approximately $70,000 due to a reduction in the total number of required
directors, partially offset by lower foreign exchange gains amounting to
approximately $22,000 recorded in the first quarter of 2014 due to fluctuations
between the US dollar and the Canadian dollar.
Financial income amounted to $5,909 for the quarter compared to financial
expenses of $1,518 for the same quarter last year.
The Company ended the first quarter of 2014 with cash and cash equivalents of
$2.5 million and working capital of $2.6 million, compared to $2.1 million in
cash and cash equivalents and a working capital of $2.7 million as at December
31, 2013.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
Certain statements contained in this news release are forward-looking and are
subject to numerous risks and uncertainties, known and unknown. For further
information identifying known risks and uncertainties, relating to financial
resources, liquidity risk, volatility of share price and other important factors
that could cause actual results to differ materially from those anticipated in
the forward-looking statements, please refer to the heading Risks and
Uncertainties in Warnex's most recent annual Management's Discussion and
Analysis, which can be found at www.sedar.com. Consequently, actual results may
differ materially from the anticipated results expressed in these
forward-looking statements.
Neither NEX nor its Regulation Services Provider (as that term is defined in
policies of the NEX) accepts responsibility for the adequacy or accuracy of this
release.
Financial statements to follow.
Interim Consolidated Statements of Financial Position
(Unaudited)
March 31 December 31
2014 2013
$ $
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Assets
Current assets
Cash and cash equivalents 151,252 218,299
Short-term investments 2,300,000 1,900,000
Trade and other receivables 196,300 782,073
Prepaid expenses 32,463 55,483
----------------------------------------------------------------------------
2,680,015 2,955,855
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Liabilities
Current liabilities
Trade and other payables 73,293 169,731
Provisions - 80,000
----------------------------------------------------------------------------
73,293 249,731
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Shareholders' equity
Capital stock 41,706,049 41,706,049
Other reserves 2,803,559 2,803,559
Deficit (41,902,886) (41,803,484)
----------------------------------------------------------------------------
2,606,722 2,706,124
----------------------------------------------------------------------------
----------------------------------------------------------------------------
2,680,015 2,955,855
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Interim Consolidated Statements of Changes in Shareholders' Equity
(Unaudited)
Other reserves
---------------------------------------------
---------------------------------------------
Equity
components
Capital of Share-based Total other
stock debentures compensation Other reserves
$ $ $ $ $
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Balance, December
31, 2013 41,706,049 1,734,404 1,028,149 41,006 2,803,559
Net and
comprehensive loss - - - - -
----------------------------------------------------------------------------
Balance,March 31,
2014 41,706,049 1,734,404 1,028,149 41,006 2,803,559
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Balance, December
31, 2012 41,706,049 1,734,404 1,028,149 41,006 2,803,559
Net and
comprehensive loss - - - - -
----------------------------------------------------------------------------
Balance, March 31,
2013 41,706,049 1,734,404 1,028,149 41,006 2,803,559
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Deficit Total
$ $
----------------------------------------------
----------------------------------------------
Balance, December
31, 2013 (41,803,484) 2,706,124
Net and
comprehensive loss (99,402) (99,402)
----------------------------------------------
Balance,March 31,
2014 (41,902,886) 2,606,722
----------------------------------------------
----------------------------------------------
Balance, December
31, 2012 (39,840,541) 4,669,067
Net and
comprehensive loss (453,637) (453,637)
----------------------------------------------
Balance, March 31,
2013 (40,294,178) 4,215,430
----------------------------------------------
----------------------------------------------
Interim Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)
2014 2013
For the three months ended March 31 $ $
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Revenues - -
Operating expenses
General and administrative 105,311 452,119
Finance (5,909) 1,518
----------------------------------------------------------------------------
99,402 453,637
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Net and comprehensive loss (99,402) (453,637)
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Basic loss per share ($0.00) ($0.02)
Diluted loss per share ($0.00) ($0.02)
Weighted average number of shares outstanding 28,323,884 28,323,884
Weighted average number of diluted shares
outstanding 28,323,884 28,323,884
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Interim Consolidated Statements of Cash Flow
(Unaudited)
2014 2013
For the three months ended March 31 $ $
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Operations
Net loss (99,402) (453,637)
Net change in non-cash working capital items 432,355 285,268
----------------------------------------------------------------------------
Net cash used in operations 332,953 (168,369)
----------------------------------------------------------------------------
Investing activities
Acquisition of short-term investments (500,000) -
Disposal of short-term investments 100,000 -
----------------------------------------------------------------------------
Net cash used by investing activities (400,000) -
----------------------------------------------------------------------------
Financing activities
----------------------------------------------------------------------------
Net cash used in financing activities - -
----------------------------------------------------------------------------
Decrease in cash and cash equivalents (67,047) (168,369)
Cash and cash equivalents, beginning of period 218,299 2,742,114
----------------------------------------------------------------------------
Cash and cash equivalents, end of period 151,252 2,573,745
----------------------------------------------------------------------------
----------------------------------------------------------------------------
FOR FURTHER INFORMATION PLEASE CONTACT:
Michael Singer
Chairman of the Board of Directors
Warnex Inc.
(514) 940-3600
info@warnex.ca
Warnex (TSXV:WNX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Warnex (TSXV:WNX)
Historical Stock Chart
From Nov 2023 to Nov 2024
